Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim Products

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health

This publication has 29 references indexed in Scilit: